Cargando…
Complementary Methods in Cancer Treatment—Cure or Curse?
(1) Background: The prevalence of complementary and alternative methods (CAM) use among oncological patients has been rising constantly over the last few decades and a variety of both pharmacological and non-pharmacological methods have been developed. Many advertisements promise to relieve side eff...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796472/ https://www.ncbi.nlm.nih.gov/pubmed/33466517 http://dx.doi.org/10.3390/ijerph18010356 |
_version_ | 1783634690394030080 |
---|---|
author | Michalczyk, Kaja Pawlik, Jakub Czekawy, Izabela Kozłowski, Mateusz Cymbaluk-Płoska, Aneta |
author_facet | Michalczyk, Kaja Pawlik, Jakub Czekawy, Izabela Kozłowski, Mateusz Cymbaluk-Płoska, Aneta |
author_sort | Michalczyk, Kaja |
collection | PubMed |
description | (1) Background: The prevalence of complementary and alternative methods (CAM) use among oncological patients has been rising constantly over the last few decades and a variety of both pharmacological and non-pharmacological methods have been developed. Many advertisements promise to relieve side effects of chemotherapy or even to cure the disease, thus encouraging patients to use CAM; (2) Methods: The objective of the study was to determine which patients’ characteristics are associated with the use of complementary medicine during cancer treatment, their pattern of use, and if it has any association with its safety profile. This survey-based prospective multicenter study of 316 patients examined the use of complementary medicine among patients undergoing chemotherapy treatment in cancer centers in Poland between 2017 and 2019; (3) Results: The Chi2 analysis showed that patients’ opinion regarding the safety of unconventional methods is related to the use of CAM (p = 0.00147). Moreover, patients’ thinking that alternative medicine can replace traditional therapy was correlated with his/her education (p = 0.01198). Moreover, we performed univariate and multivariate analysis to determine factors associated with CAM use including sociodemographic and clinical characteristics. Finally, we conducted survival analysis of patients undergoing chemotherapy treatment with 42 months of follow-up time of our prospective study. Using Kaplan–Meier curves and log-rank analysis, we found no statistical difference in overall survival between the groups that used and did not use any form of CAM (p = 0.211); (4) Conclusions: CAM use is common among patients undergoing chemotherapy treatment and should be considered by medical teams as some agents may interact with chemotherapy drugs and affect their efficacy or cause adverse effects. |
format | Online Article Text |
id | pubmed-7796472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77964722021-01-10 Complementary Methods in Cancer Treatment—Cure or Curse? Michalczyk, Kaja Pawlik, Jakub Czekawy, Izabela Kozłowski, Mateusz Cymbaluk-Płoska, Aneta Int J Environ Res Public Health Article (1) Background: The prevalence of complementary and alternative methods (CAM) use among oncological patients has been rising constantly over the last few decades and a variety of both pharmacological and non-pharmacological methods have been developed. Many advertisements promise to relieve side effects of chemotherapy or even to cure the disease, thus encouraging patients to use CAM; (2) Methods: The objective of the study was to determine which patients’ characteristics are associated with the use of complementary medicine during cancer treatment, their pattern of use, and if it has any association with its safety profile. This survey-based prospective multicenter study of 316 patients examined the use of complementary medicine among patients undergoing chemotherapy treatment in cancer centers in Poland between 2017 and 2019; (3) Results: The Chi2 analysis showed that patients’ opinion regarding the safety of unconventional methods is related to the use of CAM (p = 0.00147). Moreover, patients’ thinking that alternative medicine can replace traditional therapy was correlated with his/her education (p = 0.01198). Moreover, we performed univariate and multivariate analysis to determine factors associated with CAM use including sociodemographic and clinical characteristics. Finally, we conducted survival analysis of patients undergoing chemotherapy treatment with 42 months of follow-up time of our prospective study. Using Kaplan–Meier curves and log-rank analysis, we found no statistical difference in overall survival between the groups that used and did not use any form of CAM (p = 0.211); (4) Conclusions: CAM use is common among patients undergoing chemotherapy treatment and should be considered by medical teams as some agents may interact with chemotherapy drugs and affect their efficacy or cause adverse effects. MDPI 2021-01-05 2021-01 /pmc/articles/PMC7796472/ /pubmed/33466517 http://dx.doi.org/10.3390/ijerph18010356 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Michalczyk, Kaja Pawlik, Jakub Czekawy, Izabela Kozłowski, Mateusz Cymbaluk-Płoska, Aneta Complementary Methods in Cancer Treatment—Cure or Curse? |
title | Complementary Methods in Cancer Treatment—Cure or Curse? |
title_full | Complementary Methods in Cancer Treatment—Cure or Curse? |
title_fullStr | Complementary Methods in Cancer Treatment—Cure or Curse? |
title_full_unstemmed | Complementary Methods in Cancer Treatment—Cure or Curse? |
title_short | Complementary Methods in Cancer Treatment—Cure or Curse? |
title_sort | complementary methods in cancer treatment—cure or curse? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796472/ https://www.ncbi.nlm.nih.gov/pubmed/33466517 http://dx.doi.org/10.3390/ijerph18010356 |
work_keys_str_mv | AT michalczykkaja complementarymethodsincancertreatmentcureorcurse AT pawlikjakub complementarymethodsincancertreatmentcureorcurse AT czekawyizabela complementarymethodsincancertreatmentcureorcurse AT kozłowskimateusz complementarymethodsincancertreatmentcureorcurse AT cymbalukpłoskaaneta complementarymethodsincancertreatmentcureorcurse |